drugset / Trial / NCT01470339
Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation Profile
RandomizedParallel-groupDouble-blind
Summary
* To delineate brain mechanisms that subserve endogenous analgesic (EA) in the healthy state. * To identify alterations in mechanisms supporting EA in chronic pain (migraine) and their therapeutic relevance.
Timeline
- Start
- 2011-12
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Duloxetine | Small molecule | 60 mg | — |
Indications
No indication recorded.